schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
https://grassfed.us/Breutzmann-mother-of-Alar-from-Fredericton
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.